Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Inventory (2018 - 2025)

AVITA Medical's Inventory history spans 8 years, with the latest figure at $6.9 million for Q4 2025.

  • For Q4 2025, Inventory fell 4.72% year-over-year to $6.9 million; the TTM value through Dec 2025 reached $6.9 million, down 4.72%, while the annual FY2025 figure was $6.9 million, 4.72% down from the prior year.
  • Inventory reached $6.9 million in Q4 2025 per RCEL's latest filing, down from $7.2 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $8.4 million in Q1 2025 to a low of $1.6 million in Q2 2021.
  • Average Inventory over 5 years is $4.4 million, with a median of $3.7 million recorded in 2023.
  • Peak YoY movement for Inventory: decreased 6.86% in 2021, then surged 163.34% in 2023.
  • A 5-year view of Inventory shows it stood at $2.1 million in 2021, then decreased by 0.33% to $2.1 million in 2022, then soared by 163.34% to $5.6 million in 2023, then grew by 29.9% to $7.3 million in 2024, then dropped by 4.72% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Inventory are $6.9 million (Q4 2025), $7.2 million (Q3 2025), and $7.5 million (Q2 2025).